Process for the preparation of chroman derivatives
CA 2253141 A1 · Owner: Lonza Ag · Inventors: Jackson, Barry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Chroman derivatives of the general formula: ( C), in which R1 is hydrogen or C1-4-alkyl; R2 is C1-6-alkyl C3-6-cycloalkyl, optionally substituted aryl or optionally substituted aryl-C1-6-alkyl; R3, R5 and R6 independently of one another are hydrogen, halogen, C1-4-alkyl or optionally substituted aryl; and R4 is C1-6-alkyl C3-6-cycloalkyl, (C1-6-alkoxy)methyl, optionally substituted aryl optionally substituted aryl-C1-6-alkyl C1-6-alkanoyl or, optionally substituted aroyl are obtained from, hydroquinone derivatives and alkenes in the presence of Lewis acids. The chroman derivatives (I) are intermediates in the synthesis of pharmaceutically active substances, for example hypolipidemics.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 6, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 6, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.